D Gareth Evans

发表

Prediction of reader estimates of mammographic density using convolutional neural networks

Michael Berks, Susan M Astley, Johan Hulleman, 2019, Journal of medical imaging.

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

Diana Eccles, Susan Peock, Rosemarie Davidson, 2013, Journal of the National Cancer Institute.

Exploring the prediction performance for breast cancer risk based on volumetric mammographic density at different thresholds

Jack Cuzick, Elaine F Harkness, Adam R Brentnall, 2018, Breast Cancer Research.

The MDM2 promoter SNP285C/309G haplotype diminishes Sp1 transcription factor binding and reduces risk for breast and ovarian cancer in Caucasians.

Dongxin Lin, Peter Devilee, Caroline Seynaeve, 2011, Cancer cell.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers

Mads Thomassen, Nina Ditsch, Vijai Joseph, 2012, Breast Cancer Research.

Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Russell Davies, Iqbal Warsi, Diana Eccles, 2006, Cancer research.

Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Mads Thomassen, Nina Ditsch, Dieter Niederacher, 2009, Human molecular genetics.

Predicting Compliance in a Breast Cancer Prevention Trial

D Gareth Evans, Anthony Howell, A. Howell, 2006, The breast journal.

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Wei Lu, Wei Zheng, Mads Thomassen, 2013, Nature Genetics.

Genome-wide association study identifies five new breast cancer susceptibility loci

Deborah Hughes, Nazneen Rahman, William Tapper, 2010, Nature Genetics.

Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations

Nazneen Rahman, Carel Meijers, Julian Peto, 2002, Nature Genetics.

A Pilot Study of Compositional Analysis of the Breast and Estimation of Breast Mammographic Density Using Three-Dimensional T1-Weighted Magnetic Resonance Imaging

Michael Khazen, Iqbal Warsi, Martin O Leach, 2008, Cancer Epidemiology Biomarkers & Prevention.

A novel and fully automated mammographic texture analysis for risk prediction: results from two case-control studies

Jack Cuzick, Elaine F Harkness, Adam R Brentnall, 2017, Breast Cancer Research.

Cancers in BRCA1 and BRCA2 carriers and in women at high risk for breast cancer: MR imaging and mammographic features.

Fiona J Gilbert, Martin O Leach, D Gareth Evans, 2009, Radiology.

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Christiana Kartsonaki, Mads Thomassen, Julian Peto, 2010, Nature Genetics.

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

Peter Devilee, Alfons Meindl, Lesley McGuffog, 2010, Breast Cancer Research.

Risk determination and prevention of breast cancer

Stephen W Duffy, D Gareth Evans, Anthony Howell, 2014, Breast Cancer Research.

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

Mads Thomassen, Nina Ditsch, Muhammad Usman Rashid, 2015, JAMA.

Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer

Gord Glendon, Lesley McGuffog, Daniel Barrowdale, 2012 .

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility.

Nazneen Rahman, Carel Meijers, Sheila Seal, 2003, American journal of human genetics.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

The Fragile X Protein binds mRNAs involved in cancer progression and modulates metastasis formation

Patrick Neven, Vito Michele Fazio, Sebastian Munck, 2013, EMBO molecular medicine.

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2

Mads Thomassen, Stephen Fox, Dieter Niederacher, 2011, Breast Cancer Research.

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK)

Elisabeth Cardis, Susan Peock, Joan Paterson, 2012, BMJ : British Medical Journal.

Evaluation of RAD50 in familial breast cancer predisposition

Päivi Heikkilä, Jiri Bartek, Nazneen Rahman, 2006, International journal of cancer.

Fine-Mapping CASP8 Risk Variants in Breast Cancer

Ryan Abo, Stacey Knight, Angela Cox, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial

Rodney J Scott, Finlay Macrae, Annika Lindblom, 2011, The Lancet.

Assessing the usefulness of a novel MRI-based breast density estimation algorithm in a cohort of women at high genetic risk of breast cancer: the UK MARIBS study

Michael Khazen, Iqbal Warsi, Martin O Leach, 2009, Breast Cancer Research.

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.

Rosalind Eeles, Susan L Neuhausen, Fergus J Couch, 2010, JAMA.

Germline mutations in RAD51D confer susceptibility to ovarian cancer

Deborah Hughes, Nazneen Rahman, Elise Ruark, 2011, Nature Genetics.

Characterising the loss-of-function impact of 5’ untranslated region variants in 15,708 individuals

Tariq Ahmad, Patrick F. Sullivan, Andres Metspalu, 2019, bioRxiv.

Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness.

Stefania Tommasi, Laura Cortesi, Mads Thomassen, 2019, Cancer research.

Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Dieter Niederacher, Ute Hamann, Alfons Meindl, 2008, American journal of human genetics.